Merck's stock rises on sales of its blockbuster cancer drug Keytruda

Facebook

Merck’s net income soared 69% in the three months ending March 31, to $4.8 billion, from $2.8 billion in the same period last year. Image : Andrew Kelly ( Reuters ) Related Content Merck is paying $10.8 billion for a company with no approved drugs Johnson & Johnson is reportedly eyeing its second big heart device company acquisition HGTV's Property Brothers react to mortgage rates rising over 7% CC Share Subtitles Off English Share this Video Facebook Twitter Email Reddit Link view video HGTV's

Tag-uri: Facebook Twitter

din zilele anterioare